Merck's Keytruda approved as adjuvant therapy for stage IIb, IIc melanoma
December 03 2021 - 4:55PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Merck (NYSE:MRK)
Historical Stock Chart
From Apr 2024 to May 2024
Merck (NYSE:MRK)
Historical Stock Chart
From May 2023 to May 2024